Cedars Sinai
J

Management of Toxicity and Dose Modification Associated With Cabozantinib in HCC

By Cedars Sinai FEATURING Jun Gong
By Cedars Sinai FEATURING Jun Gong
265 views
April 19, 2024
Comments 0
Login to view comments. Click here to Login

Featured Video

13:36
Exelixis

Hypothetical Patient Case: Hepatocellular Carcinoma and Consideratio…

Feat. J. Gutierrez, J. Strauss

Featured Video

20:14
Exelixis

Hypothetical Patient Case: RAI-R Metastatic Differentiated Thyroid C…

Feat. R. Alter, R. Shameem

Recommended

Houston Methodist

Inaugural Houston Methodist Neal Cancer Center GI Oncology Symposium

Fri, Dec 6, 2024
57:44

Vogl,NY on How to Ask Good Questions at Medical Meetings

Vogl, NY

S. Vogl

5.1K views

·

1 year ago
29:25

Hyperprogression in Cancer Treated With Immunotherapy

Northwestern Medicine Oncology and Hematology

Y. Chae

1.2K views

·

7 months ago
18:21

New

GI Cancers: Hot Topics in 2024

Yale Cancer Center

J. Lacy

375 views

·

3 weeks ago
20:09

ESMO 2024 Summary: Selecting 1L Therapy and Sequencing After Immunot…

2024 ESMO Annual Meeting Insights Hub

L. Rimassa

370 views

·

2 months ago
10:57

Y90 Radioembolization for Locally Advanced HCC

UCLA Health

S. Padia

632 views

·

8 months ago
13:05

ESMO 2024 Summary: Highlights in HCC

2024 ESMO Annual Meeting Insights Hub

R. Kim, T. Biachi

195 views

·

1 month ago
15:30

Updates in Combination Therapy for HCC

Yale Cancer Center

S. Stein

456 views

·

6 months ago
04:39

ESMO 2024 Insights: TACE ± Lenvatinib + Pembro for Int-Stage HCC - P…

2024 ESMO Annual Meeting Insights Hub

J. Llovet

196 views

·

1 month ago
25:09

ASCO® 2024 Summary: "Experts Discuss Key Studies in HCC and BTC"

2024 ASCO® Annual Meeting Insights Hub

R. Kim, T. Biachi

375 views

·

5 months ago
26:59

2023 AASLD Guidance for HCC

University of Texas Southwestern Medical Center

A. Singal

815 views

·

1 year ago
16:40

Year in Review: Hepatobiliary Cancers

Moffitt Cancer Center

R. Kim, T. Biachi

604 views

·

10 months ago
09:56

ESMO 2024 Insights: HIMALAYA - 5-Year OS of Tremelimumab + Durvaluma…

2024 ESMO Annual Meeting Insights Hub

L. Rimassa

168 views

·

2 months ago
27:48

Current Approach to Frontline Systemic Therapy for Advanced Hepatoce…

Lionel Kankeu Fonkoua

260 views

·

4 months ago
13:58

ASCO® GI 2024 Summary: "HCC Key Studies Including EMERALD-1 & IMbrav…

Insights from 2024 ASCO® GI Annual Meeting

R. Kim, T. Biachi

434 views

·

9 months ago
15:53

Understanding HCC: Perspectives on Diagnosis, Risk Factors, and Trea…

Yale Cancer Center

A. Jaffe

326 views

·

6 months ago
05:40

New

ESMO 2024 Insights: CheckMate 9DW Expanded Analysis - Nivo + Ipi vs.…

2024 ESMO Annual Meeting Insights Hub

H. Karachiwala

131 views

·

4 weeks ago
14:28

ESMO 2024 Summary: Updates in HCC and Impacts on Practice

2024 ESMO Annual Meeting Insights Hub

H. Babiker

151 views

·

1 month ago
21:11

Hepatocellular Carcinoma: Current Management Strategies

Stanford Medicine

R. Dhanasekaran

230 views

·

5 months ago
22:02

ACG 2023 Highlights: HCC Updates - Diagnosis and Management

ACG 2023 Conference Coverage

R. Wong

620 views

·

1 year ago
09:41

ASCO® 2024 Summary: "HCC Highlights From the CheckMate 9DW and CARES…

2024 ASCO® Annual Meeting Insights Hub

A. Vogel

213 views

·

4 months ago
AUTOPLAY